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ABSTRACT
The alveolar epithelium represents a major site of tissue destruction
during lung injury. It consists of alveolarepithelial type I (ATI) and type II
(ATII) cells. ATII cells are capable of self-renewal and exert progenitor
function for ATI cells upon alveolar epithelial injury. Cell differentiation
pathways enabling this plasticity and allowing for proper repair,
however, are poorly understood. Here, we applied proteomics,
expression analysis and functional studies in primary murine ATII
cells to identify proteins and molecular mechanisms involved in
alveolar epithelial plasticity. Mass spectrometry of cultured ATII cells
revealed a reduction of carbonyl reductase 2 (CBR2) and an increase
in enolase 1 (ENO1) and protein disulfide-isomerase associated
3 (PDIA3) protein expression during ATII-to-ATI cell trans-
differentiation. This was accompanied by increased Wnt/β-catenin
signaling, as analyzed by qRT-PCR and immunoblotting. Notably,
ENO1 and PDIA3, along with T1α (podoplanin; an ATI cell marker),
exhibited decreased protein expression upon pharmacological and
molecular Wnt/β-catenin inhibition in cultured ATII cells, whereas
CBR2 levels were stabilized. Moreover, we analyzed primary ATII
cells frommicewith bleomycin-induced lung injury, amodel exhibiting
activatedWnt/β-catenin signaling in vivo.Weobserved reducedCBR2
significantly correlating with surfactant protein C (SFTPC), whereas
ENO1 and PDIA3 along with T1αwere increased in injured ATII cells.
Finally, siRNA-mediated knockdown of ENO1, as well as PDIA3, in
primary ATII cells led to reduced T1α expression, indicating
diminished cell trans-differentiation. Our data thus identified proteins
involved in ATII-to-ATI cell trans-differentiation and suggest a Wnt/β-
catenin-driven functional role of ENO1 and PDIA3 in alveolar
epithelial cell plasticity in lung injury and repair.
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INTRODUCTION
Chronic lung diseases, such as chronic obstructive pulmonary
disease (COPD) and idiopathic pulmonary fibrosis (IPF), represent
a significant health burden worldwide owing to their progressive
nature and the current lack of curative treatments. Therapeutic
options improving disease pathology or attenuating disease
progression are limited (Barnes, 2014; Fernandez and Eickelberg,
2012).
The alveolar epithelium constitutes a major site of injury and
tissue destruction in chronic lung disease and thus represents an area
of intensive research (Tsuji et al., 2006; Camelo et al., 2014; Selman
and Pardo, 2006). In the adult lung, the alveolar epithelium consists
largely of two morphologically distinct epithelial cell types, which
are crucial to maintain lung homeostasis. Alveolar epithelial type I
(ATI) cells are elongated squamous cells with a large cell surface,
which, owing to their close proximity to endothelial cells of the
alveolar capillaries, facilitate gas exchange in the lung. Furthermore,
ATI cells are highly water permeable, enabling and facilitating ion
transport and maintenance of lung fluid balance (Dobbs et al., 2010;
Johnson et al., 2002). Although ATI cells are not the most abundant
cell type, they cover the largest surface area of the distal lung (Stone
et al., 1992; Weibel, 2015). Alveolar epithelial type II (ATII) cells,
which exhibit a cuboidal cell morphology, account for a much larger
number of cells in the distal lung while covering a significant lower
surface area (Stone et al., 1992). ATII cells are involved in ion
transport and liquid homeostasis (Fehrenbach, 2001) but, most
importantly, ATII cells are responsible for the production, storage,
secretion and recycling of pulmonary surfactant, a complex mixture
of lipids and proteins, lining the alveolar epithelium. Surfactant
lowers the surface tension at the tissue-air barrier to allow proper
inflation and deflation of the lung during breathing (Halliday, 2008;
Lhert et al., 2007). Pulmonary surfactant also contributes to host
defense in the lung (Strunk et al., 1988). Although the general
steady-state cellular turnover of the adult lung is rather low in
comparison to other organs (Hogan et al., 2014), recent studies have
demonstrated repair capacity of the lung in response to injury
(Butler et al., 2012). In a variety of different lung injury models,
such as bleomycin-induced fibrosis, hyperoxia or viral infection,
ATII cells have been described to serve as progenitor cells for ATI
cells (Rock et al., 2011; Desai et al., 2014; Liu et al., 2011).
Furthermore, recent studies utilizing linage tracing technology have
established that ATII cells are capable of long-term self-renewal,
indicating that these cells represent a major stem-cell population in
the adult alveolar epithelium (Barkauskas et al., 2013; Desai et al.,
2014).
Pathways enabling the activation and plasticity of this cell
population in response to injury and allowing for proper repair,
however, are poorly understood. Established markers to define ATII
and ATI cell phenotypes do exist, such as surfactant proteins and
T1α (podoplanin), respectively. Markers that accurately reflect the
differentiation status of alveolar epithelial cells especially during
injury and repair processes, however, are not well characterized.
Here, we applied the model of ATII cell cultivation in vitro, in which
ATII cells trans-differentiate into an ATI-cell-like phenotype duringReceived 8 November 2014; Accepted 12 May 2015
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primary culture (Borok et al., 1994; DeMaio et al., 2009; Bhaskaran
et al., 2007), to mimic differentiation and repair processes. Recent
studies have reported that the Wnt/β-catenin pathway, an essential
developmental pathway, is activated during alveolar epithelial cell
injury and repair in general (Selman et al., 2008; Königshoff et al.,
2009; Beers and Morrisey, 2011; Ulsamer et al., 2012; Tanjore
et al., 2013), and in ATII-to-ATI cell trans-differentiation in
particular (Flozak et al., 2010; Marconett et al., 2013). The detailed
mechanism, however, of how Wnt/β-catenin signaling mediates its
cellular effects on ATII-to-ATI cell trans-differentiation, remains
elusive.
The aim of the presented study was to identify proteins
controlling ATII-to-ATI cell trans-differentiation using expression
analysis, 2D gel electrophoresis and mass spectrometry of cultured
primary murine ATII cells in vitro. Secondly, we sought to define
molecular programs and markers for differentiation associated with
the Wnt/β-catenin pathway and to investigate their relevance for
injury and repair processes in the alveolar lung epithelium. We
present for the first time evidence for β-catenin-dependent ENO1
and PDIA3 expression in alveolar epithelial injury and repair
processes.
RESULTS
Dynamic changes of alveolar epithelial markers during ATII-
to-ATI cell trans-differentiation
Isolated primary murine (pm) ATII cells exhibited a robustly
high purity and viability, and expressed specific ATII cell-marker
and tight-junction proteins as previously published (Königshoff et al.,
2009; Aumiller et al., 2013). Cytoplasmic expression of the ATII cell
marker pro surfactant protein C (proSFTPC) and the tight-junction
protein occludin (OCLN) is shown in Fig. 1A. The pmATII cells were
cultured on cell culture dishes over a period of 5 days to induce
ATII-to-ATI cell trans-differentiation and were further analyzed for
their expression pattern of ATII cell (Sftpc and Sftpa) and ATI cell
(T1α) markers, as well as for tight-junction proteins. As displayed in
Fig. 1, ATII cells are characterized by a high mRNA and protein
expression level ofATII cellmarkers Sftpc and Sftpa, which decreased
significantly over the culture period. By contrast, whereas we
observed rather stable expression of tight-junction proteins, the
expression of the ATI cell marker T1α [podoplanin (Pdpn)]
significantly increased over time, accompanied by a more flattened
cellmorphology (Fig. 1B,C).Analysis of additionalmarkers involved
in ATII-to-ATI cell trans-differentiation, such as forkhead box M1
(FoxM1), a transcription factor described to be essential for ATII-to-
ATI cell trans-differentiation in an influenza lung injury model (Liu
et al., 2011), as well as advanced glycosylation end product-specific
receptor (Ager), further supported a phenotypical switch at day 3 of
culture (supplementary material Fig. S1). These data demonstrate a
differentiation of pmATII cells towards an ATI-cell-like phenotype
under the applied culture conditions.
Proteomic analysis of trans-differentiating alveolar
epithelial cells revealed CBR2, ENO1 and PDIA3 to be
differentially expressed
To identify proteins involved in alveolar epithelial differentiation
and wound repair, we applied a proteomics approach by using 2D
gel electrophoresis (2DE) and subsequent mass spectrometry (MS)
analysis of pmATII cells cultured for 1, 3 or 5 days. A representative
image of 2D gels at day 1, day 3 and day 5 is shown in Fig. 2A. The
analysis revealed several proteins to be differentially expressed in
this process (Table 1 and supplementary material Table S1). We
verified and confirmed differentially expressed proteins identified
by 2DE and MS, using qPCR and immunoblotting. Most proteins,
including carbonyl reductase 2 (CBR2), enolase 1 (ENO1; also
known as α-enolase) and protein disulfide-isomerase associated 3
(PDIA3), were differentially expressed at the mRNA level and
protein level over time of culture (Fig. 2B,C).
Interestingly, CBR2, also known as ‘mouse lung carbonyl
reductase’ (MLCR) was one of the most downregulated proteins
over the culture period, with very similar kinetics compared to
proSFTPC expression. Moreover, ENO1, a protein involved in
glycolytic processes, and PDIA3 [also named ERp57 and GRP58
(Turano et al., 2011)], a protein disulfide isomerase,were significantly
induced and PDIA3 protein localized to T1α-positive cultured
alveolar epithelial cells at day 3 of culture (Fig. 2C and
supplementary material Fig. S2). The described role of CBR2 and
ENO1 in cellular differentiation in other organs (Wenz et al., 1992;
Lopez-Alemany et al., 2003; Ryu et al., 2012) prompted us to further
investigate the relevance of these proteins in the context of alveolar
epithelial differentiation. Furthermore, PDIA3 is involved in the
TRANSLATIONAL IMPACT
Clinical issue
Chronic lung diseases, such as chronic obstructive pulmonary disease
(COPD) and idiopathic pulmonary fibrosis (IPF), represent amajor health
burden worldwide, with no curative treatment options currently available.
These disease entities are characterized by reduced repair capacity of
the alveolar compartment, in particular by impaired trans-differentiation
of alveolar epithelial type II (ATII) to alveolar type I (ATI) cells. Thus,
advances in our understanding of alveolar epithelial plasticity during lung
injury and repair are of utmost importance. The characterization of
relevant in vitro systems is required to underpin their validity and
suitability for mechanistic studies and for identifying targets for future
clinical intervention in human chronic lung diseases. In this study, the
authors aimed to identify proteins involved in alveolar epithelial cell injury
and repair processes.
Results
Using a proteomic approach, the authors reported for the first time
carbonyl reductase 2 (CBR2), enolase 1 (ENO1) and protein disulfide
isomerase associated 3 (PDIA3) as functional alveolar epithelial cell
proteins. These proteins are altered during ATII-to-ATI cell trans-
differentiation in vitro. Reduced CBR2 expression was accompanied
by reduced expression of pro surfactant protein C (proSFTPC; an ATII
cell marker). Moreover, ENO1 and PDIA3 were increased along with the
ATI cell marker T1α. Notably, expression of ENO1, PDIA3 and T1α
decreased upon inhibition of Wnt/β-catenin signaling (a pathway that is
involved in impaired alveolar epithelial cell repair in vitro and in vivo and is
suggested as a potential therapeutic target for pulmonary fibrosis) during
ATII-to-ATI trans-differentiation, whereas CBR2 levels were stabilized.
Moreover, in primary ATII cells from bleomycin-induced lung injury – a
model exhibiting activated Wnt/β-catenin signaling and pulmonary
fibrosis in vivo – CBR2 expression was reduced, significantly
correlating with reduced pro-SFTPC, whereas ENO1, PDIA3 and T1α
were increased. Finally, loss of ENO1 and PDIA3 function in primary ATII
cells led to reduced T1α expression, indicating their functional role in
alveolar epithelial cell plasticity.
Implications and future directions
In summary, these data validate the ATII-to-ATI cell trans-
differentiation in vitro system as a suitable model of alveolar
epithelial cell injury and wound repair in vivo. In addition, this study
implies CBR2, ENO1 and PDIA3 as newly identified alveolar epithelial
cell proteins involved in β-catenin-driven alveolar epithelial cell
plasticity. Therefore, these proteins might represent potential drug
targets in chronic lung disease.
878


















quality control of newly synthesized glycoproteins, suggesting a
possible connection to aberrantly activatedWnt/β-catenin signaling in
lung injury and repair (Chilosi et al., 2003; Königshoff et al., 2008,
2009).
Alveolar epithelial cell trans-differentiation is accompanied
by an activation of the Wnt/β-catenin pathway
Because the Wnt/β-catenin pathway has been described to be
involved in relevant developmental and regenerative processes in
Fig. 1. Dynamic mRNA and protein expression changes during ATII-to-ATI cell trans-differentiation in vitro. (A) Immunofluorescence staining of pmATII
cells on coverslips for epithelial cell marker expression at day 2 after isolation. Fluorescent images represent a 400× magnification. The scale bar represents
50 µm. (B) mRNA expressions of epithelial cell markers during the culture of pmATII cells over a period of 5 days. mRNA levels were measured by quantitative
RT-PCR (qRT-PCR) and normalized to Hprt as housekeeping gene. Data represent means of ΔCt values+s.e.m. of at least three independent experiments.
(C) Protein expression of epithelial markers in cultured pmATII cells. Cells were lysed at the indicated time points and 15 µg of total protein per sample was
subjected to immunoblot analysis. β-actin expression served as loading control. A representative experiment and a densitometric analysis of at least three
independent experiments are shown. Means at indicated time points were compared to day 1 (d1) using one-way ANOVA, followed by Dunnett’s post-hoc test.
Significance: *P<0.05; **P<0.01; ***P<0.001.
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the lung in general (Beers and Morrisey, 2011), as well as in lung
injury and repair processes in particular (Flozak et al., 2010;
Aumiller et al., 2013; Königshoff et al., 2009), we asked the
question, are the newly identified proteins linked to Wnt/β-catenin
signaling? First, we investigated Wnt/β-catenin activity in our
model. Importantly, we found a considerably increased level of
active β-catenin (ABC) at day 3 and day 5 accompanied by
increased T1α expression (Figs 3A and 1C), which is in accordance
to previous findings in rat alveolar epithelial cells (Flozak et al.,
2010). In order to determine whether the activation of β-catenin is
Fig. 2. CBR2, ENO1 and PDIA3 are differentially expressed during ATII-to-ATI cell trans-differentiation. pmATII cells were isolated and cultured for
the indicated time points (days). (A) Protein profile of primary mouse alveolar epithelial cells cultured for 1, 3 or 5 days was generated by subjecting 30 µg
total protein to a 2D-PAGE. Circlesmark protein spots which were identified and quantified byMALDI-TOFmass spectrometry and are differently expressed at the
indicated time points. A representative image of three independent experiments for each time point is shown. (B) mRNA expression of Cbr2, Eno1 and Pdia3
was determined by qRT-PCR and normalized to Hprt. Data represent means of ΔCt values+s.e.m. of at least three independent experiments. (C) Protein
expression was determined by subjecting 15 µg of total protein per sample to immunoblot analysis. β-actin expression served as loading control. A representative
experiment and a densitometric analysis of at least three independent experiments are shown. Means at indicated time points were compared to day 1 (d1) using
one-way ANOVA, followed by the Dunnett’s post-hoc test. Significance: *P<0.05; **P<0.01; ***P<0.001.
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mediated by a Wnt-ligand-dependent signaling process, we
determined the expression and phosphorylation status of dishevelled
segment polarity protein 3 (DVL3), a cytoplasmic protein, which is
phosphorylated and therefore activated upon binding of a Wnt ligand
to a Wnt receptor (frizzled) and co-receptor (low-density lipoprotein
receptor-related protein 5 or 6). As displayed in Fig. 3B, we observed
an increase in DVL3 phosphorylation as early as day 3, indicating that
activation of β-catenin is driven at least in part by a Wnt-ligand/
receptor-dependent mechanism. This was further substantiated by a
significant increase of mRNAs of the direct β-catenin-dependent
target genes Axin2 and Dickkopf-related protein 2 (Dkk2), detected
during the trans-differentiation of ATII cells [Fig. 3C; Axin2: ΔCt day
1 (d1) −4.56+ 0.34 s.e.m., ΔCt day 5 (d5) −0.72+0.37 s.e.m.,
P<0.001; Dkk2: ΔCt d1−6.47+0.06 s.e.m., ΔCt d5−0.99+0.31
s.e.m., P<0.001].
Next, we investigated the expression of the canonicalWnt ligands
Wnt3a,Wnt10a andWnt10b (Baarsma et al., 2013) to further clarify
which Wnt ligands might induce active Wnt signaling in this
process. Notably, we found that Wnt10a and Wnt10b, but not
Wnt3a, exhibited a remarkable increased expression as early as
day 2, linking these Wnt ligands to ATII-to-ATI cell trans-
differentiation (Fig. 3D; Wnt10a: ΔCt d1 −9.15+0.63 s.e.m., ΔCt
d5 −4.27+0.79 s.e.m., P<0.001; Wnt10b: ΔCt d1 −11.01+0.40
s.e.m., ΔCt d5 −5.05+0.67 s.e.m., P<0.001).
Inhibition of β-catenin activation inhibits pmATII cell trans-
differentiation and regulates CBR2, ENO1 and PDIA3
expression
The activation of theWnt/β-catenin pathway in our model of ATII-to-
ATI cell trans-differentiation prompted us to evaluate if the newly
identified proteins are regulated by active β-catenin signaling. In order
to do so, we treated pmATII cells with PKF115-584, a well-known
compound inhibiting the T cell factor (TCF)–β-catenin complex
(Lepourcelet et al., 2004). Inhibition of β-catenin in ATII cells led to
significantly decreased expression of ABC at day 3 and day 5,
indicating successful inhibition in pmATII cells (Fig. 4A,B).
Moreover, the inhibition of ABC led to a significant inhibition of
T1α induction at day 3 (d3) and day 5 (d5), and thus blocked
the development of an ATI-like phenotype (Fig. 4A,B; d3 42+6.83
s.e.m. % of control, P<0.001; d5 22+4.84 s.e.m. % of control,
P<0.001). Notably, determining the influence of β-catenin inhibition
on the markers identified by the proteomic approach revealed a
significantly reduced induction of ENO1 (d3 86.00+5.07 s.e.m. % of
control, P=ns; d5 60.88+9.89 s.e.m. % of control, P<0.01) and
PDIA3 (d3 42.70+3.59 s.e.m. % of control, P<0.001; d5 10.01+0.80
s.e.m. % of control,P<0.001) (Fig. 4A,B). In contrast, the expression
of CBR2, which was lost over time until day 5 under normal
conditions, was still detectable at day 5 and therefore significantly
stabilized (d3 321.5+123.1 s.e.m.% of control, P=ns; d5 1521+453.4
s.e.m. % of control, P<0.01) (Fig. 4A,B). We confirmed our results
by using another β-catenin inhibitor, which has already been applied
in an experimental lung fibrosis model in vivo (ICG-001) (Henderson
et al., 2010) (supplementary material Fig. S3). Furthermore, we
utilized an independent approach to inhibit β-catenin signaling
using siRNA-mediated downregulation of Ctnnb1 (β-catenin).
Importantly, β-catenin knockdown also led to decreased expression
of the ATI marker T1α as well as reduced ENO1 and PDIA3
expression in cultured AT cells, whereas CBR2 expression was
restored, thus further corroborating the previous findings achieved
by pharmacological inhibition (Fig. 4C,D). In a complementary
approach, we evaluated whether further activation of Wnt/β-catenin
signaling leads to enhanced trans-differentiation of pmATII cells as
well as PDIA3 and ENO1 expression. To this end, we applied the
glycogen synthase kinase-3 (GSK3) inhibitor CT99021, which is a
well-known activator of β-catenin (Uhl et al., 2015). Indeed, we
observed an induction of T1α, ENO1 and PDIA3; however, this did
not reach statistical significance, indicating that intrinsic activated
β-catenin signaling might already have reached maximal induction
(supplementary material Fig. S4).
Taken together, our data strongly support the notion that active
β-catenin signaling regulates ENO1, PDIA3 and CBR2 protein
expression in alveolar epithelial cells in vitro.
Bleomycin-induced lung injury regulates CBR2, ENO1 and
PDIA3 levels in pmATII cells
Next, we aimed to investigate whether the newly identified proteins
are involved in alveolar epithelial cell injury and repair processes in
vivo. Therefore, we utilized the murine bleomycin-induced lung
injury model, in which active Wnt/β-catenin signaling has been
demonstrated in alveolar epithelial cells (Königshoff et al., 2009;
Flozak et al., 2010). We isolated pmATII cells at day 7 and day 14
after instillation and subsequently analyzed the freshly isolated cell
Table 1. Proteins quantified on 2D gel
Protein spot
number Protein name GI accession Day 1 Day 3 Day 5
1 Calreticulin 6680836 6.2±0.31 17.7±0.04 14.6±7.5
2 Unnamed protein product 54777 4.63±1.7 14.3±2.5 19.7±3.6
3 Carbonyl reductase 2 6671688 25.8±19.3 21±3.1 10.6±7.3
4 Unnamed protein product 74197074 0.44±0.38 9.2±1.36 13.1±3.9
5 Hspd1 protein 76779273 0.8±0.73 5.7±0.85 7.9±1.83
6 Unnamed protein product 74191337 n.d. 20.4±7.2 19.8±8.2
7 Protein disulfide-isomerase associated 3 23958822 6.38±2.5 18.6±3.3 17.59±4.3
8 Krt8 protein 76779293 8.27±3.8 18.7±2.3 10.12±4.4
9 Enolase 1 54673814 0.8±0.61 4.7±1.6 5.2±1.6
10/11 ATP synthase 6680748 n.d. 5.5±1.8 4.18±2.6
12/13/14 Lamin C 1794160 0.16±0.16 3.6±1.3 5.3±2.5
15 Heat shock protein 5 29748016 3.66±1.7 17.22±4.9 15.1±3.7
16 Mitochondrial phosphoenolpyruvate carboxykinase 2 28077029 n.d. 2.2±0.08 6.0±0.63
17 Caldesmon 1 18043856 n.d. 4.4±0.48 4.7±0.9
18 Ornithine aminotransferase 8393866 1.1±0.75 4.7±0.82 4.1±1
19 Dihydrolipoyl dehydrogenase 6014973 1.02±0.8 3.05±0.1 4.47±0.7
20 Electron transferring flavoprotein 38142460 n.d. 9.24±1 5.08±2.6
n.d., not determined. Values indicate normalized fluorescence in arbitrary units.
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population (d0) on mRNA (Fig. 5A-C) and protein (Fig. 5D) level.
The analysis revealed a significant reduction of Cbr2 mRNA
expression in pmATII cells derived from bleomycin-instilled mice
compared to phosphate-buffered saline (PBS)-treated mice with a
concurrent reduction in ATII-cell-marker Sftpc expression (Fig. 5A;
Cbr2: ΔCt d7 PBS 7.48+0.06 s.e.m.; ΔCt d7 BLEO 5.02+0.46,
P<0.001; ΔCt d14 PBS 7.18+0.15 s.e.m.; ΔCt d14 BLEO 5.98+0.18
s.e.m., P<0.01; Sftpc: ΔCt d7 PBS 10.96+0.45 s.e.m.; ΔCt d7 BLEO
8.57+0.59 s.e.m., P=ns; ΔCt d14 PBS 11.36+0.52 s.e.m.; ΔCt d14
BLEO 8.92+0.78 s.e.m., P<0.05). Importantly, combined analysis
of Cbr2 and Sftpc expression using a linear regression model
revealed a significant correlation of the expression of both proteins
(r2: 0.3697; P-value: 0.0162) (Fig. 5B), suggesting that similar
regulatory pathways are involved in their expression. Similarly, we
found increased levels of Eno1 and T1α at day 7 as well as at day 14
(Fig. 5C; Eno1: ΔCt d14 PBS −0.38+0.17 s.e.m.; ΔCt d14 BLEO
1.43+0.29 s.e.m., P<0.05; T1α: ΔCt d14 PBS −1.67+0.43 s.e.m.;
ΔCt d14 BLEO 0.85+0.35, P<0.001), whereas Pdia3 levels were
decreased at day 7 but increased at day 14 upon bleomycin-induced
lung injury (Fig. 5C; Pdia3: ΔCt d7 PBS 2.11+0.08 s.e.m.; ΔCt d7
BLEO 1.69+0.06, P<0.01; ΔCt d14 PBS 1.9+0.03 s.e.m.; ΔCt d14
BLEO 2.18+0.08, P<0.001). These findings were further confirmed
on protein level (Fig. 5D). We determined increased ENO1, PDIA3
and T1α protein expression accompanied by decreased CBR2 and
proSFTPC protein expression in injured ATII cells isolated 14 days
after bleomycin-induced lung injury compared to PBS-treated lungs
(Fig. 5D). These data suggest that there is an ongoing epithelial
cell wound repair attempt in vivo as early as 7 days after induction
of injury and that this response is characterized by increased
expression of ENO1, PDIA3 and T1α.
siRNA-mediated knockdown of ENO1 and PDIA3 reduces
differentiation of pmATII cells
Finally, we asked whether modulation of ENO1 or PDIA3
expression impacts the trans-differentiation process from pmATII
cells towards a more ATI-cell-like phenotype. Therefore, we induced
siRNA-mediated knockdown of ENO1 and PDIA3, respectively, in
pmATII cells. As shown in Fig. 6A, the treatment of pmATII cells
using an ENO1-targeting siRNA pool significantly reduced ENO1
expression until day 5 [scrambled control siRNA (siScr) 78.4+9.31
Fig. 3. Wnt/β-catenin pathway is activated during ATII-to-ATI cell trans-differentiation. pmATII cells were isolated and cultured for the indicated time points
(days). (A,B) Cells were lysed using T-Per lysis buffer containing protease inhibitors and 15 µg of total protein per sample was subjected to immunoblot analysis.
β-actin expression served as loading control. A representative experiment and a densitometric analysis of at least three independent experiments is shown.
ABC, active β-catenin. (C) mRNA expression ofWnt/β-catenin target genes. (D) mRNA expression of canonical Wnt ligands. mRNA expression wasmeasured by
qRT-PCR and normalized to Hprt. Data represent means of ΔCt values+s.e.m. of at least three independent experiments. Means at indicated time points were
compared to day 1 (d1) using one-way ANOVA, followed by the Dunnett’s post-hoc test. Significance: *P<0.05; **P<0.01; ***P<0.001.
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s.e.m. % of control; siEno1 6.33+0.93 s.e.m. % of control, P<0.001].
Notably, ENO1 knockdown significantly inhibited T1α induction
compared to pmATII cells treated with the scrambled control (siScr
104.3+3.82 s.e.m. % of control; siEno1 71.39+4.19 s.e.m. % of
control, P<0.001). Similarly, we found reduced T1α expression in
pmATII cells at day 5 using an siRNA pool efficiently targeting
PDIA3 (Fig. 6B; siScr 74.72.3+9.75 s.e.m. % of control; siPdia3
43.37+16.49 s.e.m. % of control, P<0.05). Importantly, knockdown
of either ENO1 or PDIA3 did not affect cell viability in T1α-
expressing cells, as shown by WST-1 analysis (Fig. 6C). Taken
together, these data suggest a functional role of ENO1 and PDIA3 for
the process of β-catenin-driven ATII-to-ATI cell trans-
differentiation, and injury and repair, in vitro and in vivo.
DISCUSSION
Alveolar epithelial injury and remodeling is strongly associated with
chronic lung diseases. To date, several studies have demonstrated
that the population of ATII cells possesses properties of stem cells
within the adult lung alveolar epithelium in vivo (Adamson and
Bowden, 1974; Chapman et al., 2011; Barkauskas et al., 2013;
Fig. 4. β-catenin inhibition alters ATII-to-ATI cell trans-differentiation along with CBR2, ENO1 and PDIA3 expression. (A) pmATII were treated with
PKF115-584 (1 µM) or DMSO as control at day 1 after isolation until day 3 and day 5, respectively. Treated cells were lysed and subjected to immunoblot analysis.
β-actin expression served as loading control. A representative experiment is shown. (B) Densitometric analysis of at least three independent experiments using
PKF115-584 treatment. Means of the indicated groups were compared to time-matched treatment controls using one-way ANOVA, followed by Bonferroni multiple
comparison test. Significance: **P<0.01; ***P<0.001; ns, not significant. (C) pmATII cells were transfected using an siRNA pool targetingCtnnb1 and a scrambled
(siScr) control sequence, respectively. Non-transfected cells served as additional control. At day 5 cells were lysed and subjected to immunoblot analysis.
A representative experiment is shown. (D) Quantification of at least three independent experiments of Ctnnb1 siRNA treatments. Means were compared to
time-matched transfection control (siScr), using one-way ANOVA, followed by Bonferroni multiple-comparison test. Significance: *P<0.05; ***P<0.001.
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Treutlein et al., 2014; Desai et al., 2014; Vaughan et al., 2015).
In-depth characterization of alveolar epithelial subpopulations and
their function during homeostasis and disease is hampered by a
limited number of marker proteins. Here, we aimed to identify
previously unknown alveolar epithelial cell proteins and thus get
deeper insight into the molecular mechanism and programs of
alveolar epithelial cell differentiation, which is a prerequisite
for proper repair induction. To this end, we initially utilized the
model of murine ATII-to-ATI cell trans-differentiation in primary
culture in vitro. We report, for the first time, that CBR2, ENO1 and
PDIA3 are functional alveolar epithelial cell proteins. We further
investigated the relevance of these proteins for alveolar epithelial
cell trans-differentiation and cellular plasticity functionally in vitro
as well as in the bleomycin-induced lung injury mouse model
in vivo, demonstrating their involvement in alveolar epithelial injury
and repair mechanisms in a β-catenin-dependent manner.
The trans-differentiation of primary ATII cells into ATI cells
in vitro is a widely applied model to investigate alveolar epithelial
Fig. 5. ENO1, PDIA3 and CBR2 expression is altered in injured pmATII cells.Mice were instilled with either PBS or bleomycin (BLEO) (5 U/kg body weight).
At day 7 or day 14 after instillation, mice were sacrificed and lungs of four PBS- and four bleomycin-treated mice were pooled for pmATII cell isolation. (A) Freshly
isolated pmATII cells (day 0) were analyzed for mRNA expression ofCbr2 andSftpc. (B) Correlation analysis of mRNA expression ofCbr2 andSftpc using a linear
regression model. Data points represent ΔCt values for the respective genes. The corresponding regression line is indicated in red. 95% confidence intervals are
depicted by a gray scattered line. r2 and P-value is given in the graph for the compared variables. (C) Eno1, Pdia3 and T1α mRNA expression is shown using
qRT-PCR. Means of the indicated groups were compared using one-way ANOVA, followed by Bonferroni multiple-comparison test. Significance: *P<0.05;
**P<0.01; ***P<0.001; ns, not significant. (D) Protein expression of the indicated proteins in freshly isolated pmATII cells from PBS-treated or BLEO-treated mice
at day 14 after isolation. β-actin expression served as loading control.
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cell phenotypes and function, and primary ATII cells from various
species have been used (Flozak et al., 2010; Zhao et al., 2013;
Ghosh et al., 2013; Marconett et al., 2013). In the study presented
here, we detect a strong decrease of surfactant protein expression on
mRNA level as well as on protein level, whereas levels of the ATI-
cell-specific protein T1α increased and structural epithelial markers
were stably expressed. Taken together, this suggests a change in
epithelial characteristics in the direction of an ATI-like phenotype
(Fig. 1B,C). These data, gained from murine ATII cells, are in line
with studies largely using primary rat ATII cells that also
demonstrated the loss of ATII-cell-specific proteins accompanied
by an increase of ATI cell genes and stable expression of structural
epithelial cell markers, such as cytokeratin (Flozak et al., 2010;
Wang et al., 2013; DeMaio et al., 2009; Marconett et al., 2013).
Here, we mainly based our ATI-cell-like definition on the
expression of T1α along with typical morphological changes in
the AT phenotype over culture. Although other ATI cell markers
have been described, including aquaporin 5, HOP homeobox
(Hopx1) or receptor for advanced glycosylation end products
(RAGE), T1α has been established as a robust ATI cell marker
conserved over species (Flozak et al., 2010; Zhao et al., 2013;
Marconett et al., 2013; Barkauskas et al., 2013; Treutlein et al.,
2014), has been associated with an ATI cell phenotype in vivo (Yee
et al., 2006), and, most importantly, this has been confirmed in
human lung tissue (Fujino et al., 2012; Ghaedi et al., 2014;
Barkauskas et al., 2013; Marconett et al., 2013).
Although ATII cell plasticity and progenitor cell function is well-
described in vitro and in vivo, data on ATI cell function and
plasticity remain sparse. ATI cells are thought to be terminally
differentiated cells (Crosby and Waters, 2010; Weibel, 2015). It has
been reported, however, that ATI-like cells derived from in vitro
culture are capable of switching and even in part reversing their
phenotype (Borok et al., 1998; Gonzalez et al., 2009). Moreover,
recent in vivo lineage-tracing data by Jain et al. demonstrate that ATI
cells (labeled by Hopx1) can give rise to SFTPC-positive ATII cells
after pneumonectomy in vivo as well as in lung organoid cultures
Fig. 6. The siRNA-mediated knockdown of ENO1 and PDIA3 inhibits ATII-to-ATI cell trans-differentiation. pmATII cells were transfected at day 2 using
an siRNA pool targeting Eno1, Pdia3 and a scrambled (siScr) control sequence, respectively. Non-transfected cells served as additional control. At day 5 cells
were lysed and subjected to immunoblot analysis. Knockdown efficiency at day 5 was determined by detection of ENO1 and PDIA3 protein, respectively.
A representative experiment and a quantification of three independent experiments of T1α expression upon (A) ENO1 and (B) PDIA3 knockdown are shown.
Means were compared to time-matched transfection control (siScr) using one-way ANOVA followed by Bonferroni multiple-comparison test. Significance:
*P<0.05; ***P<0.001. (C) Viability of pmATII cells transfected with siScr, siEno1 or siPdia3, respectively. Analysis was performed at day 3 and day 5 using the
WST-1 assay. Data were measured in triplicates and were normalized to untreated control cells at the respective time points.
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(Jain et al., 2015). These important findings further underline that
alveolar epithelial cells exhibit an extremely high and not yet fully
understood degree of plasticity, in particular in response to lung
injury (Hogan et al., 2014).
Employing a proteomics approach, we identified several proteins
that have not yet been described in the context of ATII-to-ATI cell
trans-differentiation. A reduced expression of CBR2, a murine
carbonyl reductase, was detected in ATI-like cells, as well as in ATII
cells isolated from mice displaying bleomycin-induced lung injury,
following the same kinetics as the loss of proSFTPC. CBR2 has been
previously described to be highly expressed in the murine lung,
localizing tomitochondria of non-ciliated club cells and ciliated cells
of the bronchioles, as well as ATII cells (Matsuura et al., 1994).
Functionally, CBR2 is proposed to be involved in the metabolism of
endogenous or inhaled carbonyl compounds (Ebert et al., 2015) and,
interestingly, has also been described to be involved in cellular
differentiation, such as adipocyte differentiation (Wenz et al., 1992).
Furthermore, a function in lipid peroxidation (Ebert et al., 2015) has
been discussed for CBR2, connecting this protein to lipid
metabolism, one of highest enriched networks described in a
comprehensive joint analysis of human and rat alveolar epithelial
transdifferentiation byMarconett and colleagues (2013). This further
suggests that CBR2might be closely linked to surfactantmetabolism.
Moreover, reducedCBR2 expressionwas reported in amurinemodel
of nickel-induced acute lung injury, strengthening the potential
connection to alveolar epithelial lung injury (Wesselkamper et al.,
2005). CBR2 closely correlated with proSFTPC expression and
CBR2 levels were stabilized upon inhibition of β-catenin-dependent
ATII-to-ATI cell trans-differentiation, strongly suggesting that CBR2
can be used as an additional ATII cell marker, as well as a
functionally relevant protein in ATII cell homeostasis. Owing to the
rapid loss of thismarker in vitro, further functional cell culture studies
are limited and future studies addressing the role of CBR2 in this
context might benefit from novel 3D tissue culture models,
mimicking the natural special environment in the alveolus as well
as providing potential for cell-cell interactions.
We further demonstrated the induction of ENO1 in the context of
differentiation and alveolar epithelial injury in ATII cells. ENO1 is a
key glycolytic enzyme, displaying various functions in eukaryotic
as well as prokaryotic cells. ENO1 has been linked to migration and
invasion of glioma cells (Song et al., 2014). ENO1 has also been
described to exert its migratory function as a plasminogen receptor
at the cellular surface, supporting the degradation of extracellular
matrix molecules by plasmin (Díaz-Ramos et al., 2012). Whether its
upregulation during alveolar epithelial cell differentiation is linked
to a migratory phenotype associated with wound repair still remains
elusive. Remarkably, ENO1 seems to be required for muscle
regeneration after injury in a murine model (Lopez-Alemany et al.,
2003), linking this protein to repair, which supports our observation
of impaired trans-differentiation and possibly wound repair of ATII
cells in the presence of siRNA-mediated knockdown of ENO1
(Fig. 6A). Moreover, ENO1 was described as a serum biomarker in
hepatic fibrosis, which provides additional evidence that this protein
is crucial for organ injury and repair responses (Zhang et al., 2013).
Furthermore, the co-regulation of ENO1 with T1α in the context of
differentiation as well as induced injury is intriguing, because T1α
is not only a marker for ATI cells in the adult lung but has also been
implicated in migration and wound repair in the skin (Krishnan
et al., 2013; Honma et al., 2012).
Similar to ENO1, we found increased expression of PDIA3
involved in β-catenin-driven ATII-to-ATI cell trans-differentiation.
PDIA3 exerts diverse functions based on its expression in different
subcellular compartments (Turano et al., 2011). PDIA3 exhibits a
major role as molecular chaperone involved in the quality control
process for newly synthesized glycoproteins in the endoplasmic
reticulum (ER), interacting with calnexin or calreticulin (Oliver
et al., 1999). Interestingly, we also found increased calreticulin in
our in vitro screen as well as in injured ATII cells in vivo (data not
shown), which might suggest that both proteins are involved in
cellular stress responses in vitro and in vivo. PDIA3 has previously
been associated with ER stress following lung injury (Robertson
et al., 2002), as well as enhanced apoptosis and dysregulated repair
(Anathy et al., 2012). In renal fibrosis, PDIA3 has been shown to
contribute to extracellular matrix accumulation (Dihazi et al., 2013),
which supports our observation of increased PDIA3 expression in
injured and fibrotic ATII cells from bleomycin-treated lungs 14 days
after injury. Taken together, these data suggest that induction of
PDIA3 during ATII-to-ATI cell trans-differentiation reflects an
initial (impaired) repair response, which might ultimately result in
fibrosis development.
The Wnt/β-catenin pathway represents a crucial component of the
attempted repair response in lung injury and fibrosis. Active signaling
of developmental pathways, including the Wnt/β-catenin pathway,
has been demonstrated to be involved in lung tissue development
(Beers and Morrisey, 2011) and in repair and regenerative processes
(Königshoff and Eickelberg, 2010; Liu et al., 2011). In particular,
Wnt/β-catenin signaling has been linked to insufficient or
dysregulated repair in chronic lung disease, including IPF and
COPD, as well as experimental models thereof (Selman et al., 2008;
Kneidinger et al., 2011; Königshoff et al., 2009; Wang et al., 2011;
Uhl et al., 2015). Here, we demonstrate activation of Wnt-ligand-
dependent β-catenin signaling by increasedABC and phosphorylated
DVL3 levels, as well as target gene induction, implying a Wnt-
ligand-dependent mechanism (Fig. 3). These results are in agreement
with findings in rat ATII by Flozak et al. (2010). Here, we report that
the canonical Wnt ligands Wnt10a and Wnt10b represent potential
Wnt ligands driving this process and future studies will clarify the
contribution of differentWnt ligands. Interestingly, overexpression of
Wnt10b has been shown to contribute to the development of skin
fibrosis (Akhmetshina et al., 2012). Furthermore, Wang and
colleagues link the activation of Wnt/β-catenin signaling to a
decreased expression of microRNA miR-375, regulating the
expression of Wnt receptor frizzled 8 (FZD8), a predicted and
confirmed target of miR-375 (Wang et al., 2013). Wnt/β-catenin
signaling has been further identified and confirmed by a
comprehensive transcriptomic and epigenomic analysis describing
the Wnt/β-catenin pathway as concomitantly regulated in rat and
human trans-differentiating ATII cells (Marconett et al., 2013).
Notably, expression of the newly identified proteins CBR2, ENO1
and PDIA3 was altered upon pharmacological as well as molecular
β-catenin inhibition (Fig. 4, supplementary material Fig. S3),
suggesting that the newly identified proteins function downstream
of β-catenin signaling and thus further corroborating that β-catenin is
a key regulator of alveolar epithelial cellular plasticity. Of note, we
observed stabilized CBR2 level upon β-catenin inhibition, a marker
that is closely linked to SFTPC expression, thereby supporting the
notion that β-catenin inhibition might also promote ATII cell
homeostasis and function. Protein levels of SFTPC, however, were
not detectable in our cultured cells, which might be due to a limited
sensitivity of the protein analysis by western blotting. Moreover,
other essential factors, such as stretch and 3D structure, are missing in
our culture model. Future studies using advanced ATII-to-ATI cell
trans-differentiation models are needed to further investigate SFTPC
metabolism upon β-catenin, ENO1 and/or PDIA3 modulation.
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It has to be pointed out that the involvement of additional
developmental pathways, such as transforming growth factor β
(TGFβ) and bone morphogenetic protein (BMP) signaling, in
alveolar epithelial ATII-to-ATI cell trans-differentiation (Bhaskaran
et al., 2007; Zhao et al., 2013) has been demonstrated. This suggests
a high complexity of interacting pathways with potential direct
or indirect crosstalk at multiple levels. Along this line, inhibition of
β-catenin signaling has been shown by several groups to attenuate
bleomycin-induced lung fibrosis in vivo (Ulsamer et al., 2012;
Henderson et al., 2010). Thus, although initial β-catenin signaling
seems to be relevant to initiate wound repair, crosstalk of Wnt/β-
catenin with other pathways might interfere with proper repair and
result in fibrosis (Königshoff and Eickelberg, 2010; Ulsamer et al.,
2012; Tanjore et al., 2013; Lam et al., 2014). Future studies are
needed to further delineate signaling crosstalk, which also needs to
be considered for the development of novel therapies and drugs
aiming to modulate impaired lung injury and repair.
In summary, our data indicate that the model of ATII-to-ATI cell
trans-differentiation in vitro is a suitable alveolar epithelial cell
injury and wound repair model that closely mimics the ongoing
repair attempts as observed in lung injury and fibrosis in vivo. We
demonstrate that CBR2, ENO1 and PDIA3 are newly identified
alveolar epithelial cell proteins involved in β-catenin-driven ATII-
to-ATI cell trans-differentiation, thus contributing to alveolar
epithelial cell plasticity in lung injury and fibrosis.
MATERIALS AND METHODS
Animals
Eight- to ten-week-old, pathogen-free female C57BL/6N mice (Charles
River Laboratories, Sulzfeld, Germany) were used for all experiments,
which were conducted according to the Ethics Committee guidelines of the
Helmholtz Zentrum München and Government of Bavaria. Mice had free
access to water and rodent laboratory chow. For the induction of lung injury,
mice were subjected to intratracheal bleomycin instillation. Bleomycin
sulfate (Almirall, Barcelona, Spain) was dissolved in sterile PBS and applied
using the Micro-Sprayer Aerosolizer, Model IA-1C (Penn-Century,
Wyndmoor, PA), as a single dose of 0.08 mg in 200 µl solution per
animal (5 U/kg body weight). Control mice were treated with 200 µl PBS.
Mice were sacrificed at day 7 or day 14 after instillation for collection of
ATII cells.
Primary murine ATII cell isolation and culture
Primary murine (pm) ATII cell isolation was performed as previously
described (Corti et al., 1996; Königshoff et al., 2009). In brief, lungs of 8- to
10-week-old, pathogen-free female C57BL/6N mice (Charles River
Laboratories, Sulzfeld, Germany) were lavaged with 500 µl of PBS twice.
Lungs were flushed through the right heart using 0.9% NaCl solution
(B. Braun Melsungen AG, Melsungen, Germany), inflated with 1.5 ml
dispase (BDBioscience, San Jose, CA) followed by 300 µl 1% low-melting-
point agarose (Sigma-Aldrich, St Louis, MO) and incubated for 45 min at
room temperature (RT). Subsequently, lungs were minced, filtered through
100 µm, 20 µm and 10 μm nylon meshes (Sefar, Heiden, Switzerland) and
the cell suspension was centrifuged at 200 g for 10 min. The cell pellet was
resuspended in DMEM cell culture medium (Sigma-Aldrich) and negative
selection for macrophages and lymphocytes was performed by incubation of
the single cell suspension on Petri dishes coated with antibodies against
CD45 and CD16/32 (both BD Biosciences) for 30 min at 37°C. Non-
adherent cells were collected and negative selection for fibroblasts was
performed by adherence for 25 min on cell culture dishes. Cells were
collected and cell viability was assessed by trypan blue exclusion. Cell
purity was assessed by immunofluorescence staining of cells cultured
overnight on chamber slides for proSFTPC, panCK, T1α, CD45, CD31 and
αSMA. pmATII cells were resuspended in DMEM containing 10% FCS
(PAA Laboratories, Pasching, Austria), 2 mM l-glutamine, 1% penicillin/
streptomycin (both Life Technologies, Carlsbad, CA), 3.6 mg/ml glucose
(Applichem GmbH, Darmstadt, Germany) and 10 mM HEPES (PAA
Laboratories), and cultured for 24 h to allow attachment. Medium was
changed and cells were cultured up to 5 days in a humidified atmosphere of
5% CO2 at 37°C with a medium change every other day.
Cell culture treatments
PKF115-584-mediated inhibition of β-catenin activity in pmATII cells was
performed by treatment with a concentration of 1 µM beginning at day 1 of
culture until day 3 and day 5, respectively. Control cells were treated with the
corresponding concentration of DMSO. Treatment and control media were
refreshed at day 3. ICG-001 treatment (7.5 µM) was applied in the same
manner. CT99021 treatment (2 µM) of cells was performed from day 1 to
day 3. DMSO-treated cells served as control. The pharmacological
inhibitors were purchased from the following companies: PKF115-584
(Santa Cruz), ICG-001 (Biomol) CT99021 (Tocris). siRNA-mediated
downregulation of Ctnnb1, Eno1 or Pdia3 (ERp57) was performed using an
siRNA pool of three target-specific siRNAs (Ctnnb1 siRNA, α-Enolase
siRNA, ERp57 siRNA, Santa Cruz Biotechnology, Dallas, TX). Cells were
transfected at day 2 after isolation using Lipofectamine RNAiMAX
Transfection Reagent (Life Technologies) according to the manufacturer’s
instructions. Cells transfected with a scrambled control siRNA (siScr)
(Santa Cruz Biotechnology, Dallas, TX) served as control. Non-transfected
cells served as additional control. Cells were analyzed at day 5. siRNA
efficiency was confirmed on mRNA level (data not shown) and protein level
(Figs 4C and 6A,B).
Cell viability assay
Cell viability analysis following ENO1 or PDIA3 siRNA-mediated
knockdown was performed using the WST-1 assay (Roche, Basel,
Switzerland) according to the manufacturer’s instructions. The assay was
performed at day 3 and day 5 and measured in triplicates.
Immunofluorescence staining
Immunofluorescence staining was performed either on pmATII cells
cultured overnight on chamber slides (BD Biosciences) for purity control
or on cells cultured for 48 h on poly-l-lysine-coated coverslips for epithelial
characterization. Cells were fixed with acetone/methanol (1:1), and blocked
with 5% (w/vol) bovine serum albumin (BSA; Sigma-Aldrich) for 30 min.
Cells were subsequently incubated with the respective primary antibody at
RT for 1 h in PBS containing 0.1% (w/vol) BSA, followed by incubation
with the fluorescently labeled secondary antibody (goat anti-rabbit Alexa
Fluor 555, Life Technologies). DAPI staining (Roche) was used to visualize
cell nuclei. Primary antibodies applied are the following: proSFTPC (Merck
Millipore, Darmstadt, Germany), OCLN (Life Technologies), T1α (R&D
Systems), PDIA3 (Abcam, Cambridge, UK).
Quantitative (q)RT-PCR
Total RNA from pmATII was extracted using the QIAGEN RNeasy Mini
Kit (Qiagen, Hilden, Germany) according to the manufacturer’s
instructions. cDNA of all samples was generated by reverse transcription
using SuperScriptII (Life Technologies). Quantitative real-time PCR (qRT-
PCR) was performed using SYBR Green and the LightCycler 480 System
(both Roche). Hypoxanthine guanine phosphoribosyl transferase (Hprt) was
utilized as a reference gene in all qRT-PCR reactions. The following primers
were used in a final concentration of 200 nM: Ager (NM_007425.3;
NM_001271422.1; NM_001271423.1), fw 5′-CTCGAATCCTCCCCAAT-
GGT-3′, rv 5′-CCAGGAATCTGGTAGACTCGG; Axin2 (NM_015732.4),
fw 5′-AGCAGAGGGACAGGAACCA-3′, rv 5′-CACTTGCCAGTTTCT-
TTGGCT-3′; Cbr2 (NM_007621.2), fw 5′-AGGAAGTTCGCAGAGGTT-
GA-3′, rv 5′-GGCAACTGAGCAGACTAGGA-3′; Cdh1 (NM_009864.2),
fw 5′-CCATCCTCGGAATCCTTGG-3′, rv 5′-TTTGACCACCGTTCT-
CCTCC-3′; Dkk2 (NM_020265.4), fw 5′-GAGATCGCAACCATGGT-
CACT-3′, rv 5′-GGGTCTCCTTCATGTCCTTTTATATG-3′; Eno1
(NM_023119.2), fw 5′-ACCCTCTTTCCTTGCTTTGC-3′, rv 5′-GAA-
GAGACCTTTTGCGGTGT-3′; FoxM1 (NM_008021.4), fw 5′-ACGCT-
GGACAACAGCTTAAC-3′, rv 5′-AGGGCTCCTCAACCTTAACC-3′;
Hprt (NM_013556.2), fw 5′-CCTAAGATGAGCGCAAGTTGAA-3′, rv
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5′-CCACAGGACTAGAACACCTGCTAA-3′; Pdia3 (NM_007952.2), fw
5′-AGCAAAGGTGGATTGCACTG-3′, rv 5′-CCATCATAAGCACCCG-
CTTC-3′; Sftpa (NM_023134.4), fw 5′-GGAGAGCCTGGAGAAAG-
GGGGC-3′, rv 5′-ATCCTTGCAAGCTGAGGACTCCC-3′; Sftpc
(NM_011359.2), fw 5′-AGCAAAGAGGTCCTGATGGA-3′, rv 5′-GAG-
CAGAGCCCCTACAATCA-3′; T1α (NM_010329.2), fw 5′-ACAGGTG-
CTACTGGAGGGCTT-3′, rv 5′-TCCTCTAAGGGAGGCTTCGTC-3′;
Tjp1 (NM_009386.2; NM_001163574.1), fw 5′-ACGAGATGCTGGGACT-
GACC-3′, rv 5′-AACCGCATTTGGCGTTACAT-3′;Wnt3a (NM_009522.2),
fw 5′-GCACCACCGTCAGCAACA-3′, rv 5′-GGGTGGCTTTGTCCAGA-
ACA-3′; Wnt10a (NM_009518.2), fw 5′-GCCCCATCTTCAGCCGAGGT-
TT-3′, rv 5′-CGTCGCAACCGCAAGCCTTC-3′; Wnt10b (NM_011718.2),
fw 5′-TGGGACGCCAGGTGGTAA-3′, rv 5′-CTGACGTTCCATGG-
CATTTG-3′. Relative transcript levels are expressed in ΔCt values
(ΔCt=Ctreference−Cttarget) or log-fold change (ΔΔCt values).
Immunoblotting
Cells were washed twice with PBS (PAA Laboratories), lysed in T-PER lysis
buffer (Thermo Fisher Scientific, Waltham, MA) supplemented with
proteinase inhibitor cocktail tablets (Roche), and lysates were centrifuged at
5660 g at 4°C. Supernatant was collected and protein concentration was
determined using the Quick Start Bradford Dye Reagent according to the
manufacturer’s instructions. 15 µg of total protein was separated on SDS-
polyacrylamide gels and transferred to nitrocellulose membranes (Bio-Rad,
Hercules, CA). Membranes were blocked in 5% nonfat dry milk (Applichem)
or 5% BSA (Sigma-Aldrich) in TRIS-buffered saline containing 0.05% (v/v)
Tween (TBST) (Applichem) and incubated with the primary antibody at 4°C
overnight. The respective HRP-labeled secondary antibody (anti-rabbit-HRP
antibody and anti-mouse-HRP antibody, both GE Healthcare, Chalfont St
Giles, UK; anti-goat-HRP, Life Technologies) was applied after washing of
the membrane in TBST. Proteins were visualized using the SuperSignal West
Dura Chemiluminescent Substrate (Thermo Fisher Scientific) and the
ChemiDoc™ XRS+ system (Bio-Rad). The following primary antibodies
were used: proSFTPC (Abcam), T1α (R&D Systems), active β-catenin
(ABC; Merck Millipore), CBR2 (Avida Systems Biology, San Diego, CA),
PDIA3 (Santa Cruz Biotechnology), ENO1 (Cell Signaling), DVL3 (Santa
Cruz Biotechnology) and TJP1 (Life Technologies). β-actin served as
loading control and was detected using a HRP-conjugated anti-β-actin
antibody (Sigma-Aldrich). Densitometric analysis of band intensities was
performed using Image Lab 5.0 software from Bio-Rad.
Protein extraction for two-dimensional gel electrophoresis
Primary ATII cells were washed twice with PBS (PAA Laboratories) and
lysed in rehydration buffer (9 M urea, 4% CHAPS, 100 mM DTT) at RT.
The samples were subsequently centrifuged at 5660 g for 30 min at 20°C.
After centrifugation, the supernatant was collected and the protein
concentrations were determined by Quick Start Bradford Dye Reagent
using a SmartSpec 3000 spectrophotometer (both Bio-Rad Laboratories).
Two-dimensional electrophoresis
Isoelectric focusing (IEF) was carried out using the PROTEAN IEF Cell
and immobilized pH gradient (IPG) strips (7 cm; pH 3-10; both from Bio-
Rad Laboratories). IPG strips were rehydrated overnight at 50 V with
0.2% ampholytes and pH 3-10 (Bio-Rad Laboratories) together with
20 µg of sample for day 1, day 3 and day 5. IEF was performed under the
following conditions: 100 V, 1 h; 250 V, 1 h; 750 V, 1 h; 1000 V, 1 h;
2500 V, 1 h; 12 kV, 1 h. The strips were maintained at −80°C until further
use. Prior to second dimension, the strips were equilibrated for 15 min in
10 ml equilibration buffer [6 M urea, 0.375 M Tris-HCl (pH 8.8), 2%
(v/v) SDS, 20% (v/v) glycerol] containing 2% (w/v) DTT and subsequently
for 15 min in equilibration buffer containing 2.5% (w/v) iodoacetamide.
The separation in the second dimension was realized on SDS
polyacrylamide gels (12.5%).
2D-gel analysis
The gels were individually stained with SyproRuby fluorescent stain (Bio-
Rad Laboratories) according to the manufacturer’s instructions. All gels
were scanned at 100 mm resolution using the Molecular Imager FX™ at an
excitation wavelength of 532 nm and an emission wavelength filter of
610 nm. Images produced from three independent extracts for each time
point were converted into digital TIF files. Spot detection, pattern evaluation
and normalization were performed using the PDQuest 2-D Analysis
Software (version 7.2, Bio-Rad Laboratories). One gel from day 3 cell
culture was set as master gel. Protein spots were automatically detected and
visually checked for undetected or incorrectly detected spots and then
matched to their corresponding spots in a digitized master gel. Intensity
levels were normalized between gels by the total quantity in valid spots of
gel images. In order to excise proteins or polypeptides from the gels they
were visualized by silver staining.
Tryptic digestion and MALDI-TOF MS
Proteins were identified using Pick’n’Post Protein identification service
(Alphalyse, Odense, Denmark). Briefly, gel-excised protein spots were
reduced, alkylated with iodoacetamide, and digested with trypsin. The
resulting peptides were concentrated on a Zip-Tip C18 column (Merk
Millipore) and eluted onto an anchorchip target for analysis on a Bruker
Autoflex III MALDI TOF/TOF instrument (Billerica, MA). The peptide
mixture was analyzed in positive reflector mode for accurate peptide mass
determination and some of the peptides analyzed by MS/MS fragmentation
for partial-peptide sequencing. For acquisition of peptide mass fingerprint
spectra (PMF, MS), 3000 single-shot spectra were averaged and the peak
finding was undertaken using the SNAP algorithm. Peptide fragmentation
spectra (PFF, MS/MS) were acquired when possible. The MS and MS/MS
spectra were combined and used for aMASCOT database search (MASCOT
version 2.1.03) in the NCBI protein database. For PFF spectra, the mass
tolerance was set at 60 ppm, allowing one missed cleavage site.
Statistical analysis
Results are presented as mean+s.e.m. and were considered statistically
significant when P<0.05. Means of respective groups were compared using
a one-way ANOVA, followed by the Dunnett’s post-hoc test or Bonferroni
multiple-comparison test or two-tailed t-test as indicated in the figure
legends. Linear regression analysis was used to determine correlation of
mRNA expression of different genes. All statistical analysis was performed
using GraphPad Prism5.
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